Japan wants to develop a new type of cancer treatment device "quantum scalpel" within 10 years

Release date: 2016-12-20

According to a report by the Japanese Kyodo News Agency on December 13, the development of new cancer treatment equipment, Hitachi, Mitsubishi Electric, Toshiba, Sumitomo Heavy Industries, four manufacturers and quantum science and technology research and development institutions (located in Chiba City) signed on the 13th The agreement will use laser technology to transform heavy particle beam therapy equipment into a small, low-cost device called a "quantum scalpel", and strive to put it into practical use in about 10 years, which is expected to reduce treatment costs.

Therapy to illuminate cancer cells by irradiating carbon ions is called heavy particle beam therapy. This therapy only attacks the lesion locally, so it is considered to have a small burden on the human body. Although the therapy currently requires a large accelerator of a large football field, the device is reduced to a length of about 20 meters and a width of about 10 meters by using strong rays. In addition, the types of ions used will be increased to achieve more effective treatment.

In the future, the installation cost will be reduced by more than 10 billion yen, and equipment will be popularized in general hospitals. The treatment fee for heavy particle beam therapy is 2.5 million yen (about 150,000 yuan) to 3 million yen, but it is said that new equipment may reduce the cost of treatment to about 1 million yen.

With the signing of the agreement, companies will share research costs and share core technologies. The market size of new equipment is considered to be more than 1 trillion yen, and four companies and research institutes are striving to lead the world in launching products and exporting them.

The Institute also plans to apply the technology accumulated during the development process to other areas such as nuclear fusion.

Source: World Wide Web

COVID-19 Solution Test Kit

SARS-CoV-2 Antigen Detection Kit applies immunoassay that uses highly sensitive monoclonal antibodies to directly detect the presence of virus. With detailed instructions and customized components, people can easily finish the detection process and rapidly get results in 10 mins. This test kit It is suitable for users over 15 years old. Children aged 2 to 15 must be swabbed and tested by an adult ( ≥ 18 years old). In addition, this kit can apply to various specified sites and scenarios.

COVID-19 Solution Test Kit

NINGBO AUTRENDS INTERNATIONAL TRADE CO., LTD , https://www.metests.com